SCHEMBL14957673

SCHEMBL14957673

O=CCc1ccc(Nc2ccccc2C(F)(F)F)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
TDP1 Q9NUW8 2/20 0.41
AURKA O14965 2/20 0.40
SLC22A12 Q96S37 2/20 0.37
CYP2C9 P11712 1/20 0.37
SLC22A6 Q4U2R8 1/20 0.37
SLC22A8 Q8TCC7 1/20 0.37
SLC22A11 Q9NSA0 1/20 0.37
KDM4E B2RXH2 2/20 0.37
EGFR P00533 1/20 0.37
KMT2A Q03164 5/20 0.36
MEN1 O00255 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
EPHX2 P34913 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
POLB P06746 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.36
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14957374 0.85 CNR2 (0.36) ALDH1A1AURKAKMT2AMEN1USP2
SCHEMBL14957637 0.84 ALDH1A1 (0.39) ALDH1A1TDP1AURKAKDM4EEGFR
SCHEMBL185856 0.83 RAB9A (0.40) ALDH1A1KDM4EKMT2AMEN1MAPT
SCHEMBL185434 0.83 OPRM1 (0.35) EGFR
SCHEMBL185313 0.82 ALDH1A1 (0.43) ALDH1A1TDP1AURKASLC22A12CYP2C9
SCHEMBL27962707 0.82 ALDH1A1 (0.43) ALDH1A1TDP1AURKASLC22A12CYP2C9
SCHEMBL186734 0.81 PTGS2 (0.41) ALDH1A1SLC22A12CYP2C9SLC22A6SLC22A8
SCHEMBL27870351 0.77 ALDH1A1 (0.43) ALDH1A1TDP1AURKASLC22A12CYP2C9
SCHEMBL2780905 0.75 FLT3 (0.57) ALDH1A1TDP1AURKAKMT2ASIRT2
SCHEMBL27870352 0.74 ALDH1A1 (0.42) ALDH1A1TDP1AURKASLC22A12CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130131075-A1 NEW COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131075-A1 NEW COMPOUNDS ADORA1, H1-10, P2RY11 ALDH1A1 1000/4885TDP1 2237/4885AURKA 3494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.